Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.
- Published In:
- ACS pharmacology & translational science, 2(2), 66-91 (2019)
- Authors:
- Glotfelty, Elliot J, Delgado, Thomas, Tovar-Y-Romo, Luis B, Luo, Yu, Hoffer, Barry, Olson, Lars, Karlsson, Tobias, Mattson, Mark P, Harvey, Brandon, Tweedie, David, Li, Yazhou, Greig, Nigel H
- Database ID:
- RPEP-04197
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04197APA
Glotfelty, Elliot J; Delgado, Thomas; Tovar-Y-Romo, Luis B; Luo, Yu; Hoffer, Barry; Olson, Lars; Karlsson, Tobias; Mattson, Mark P; Harvey, Brandon; Tweedie, David; Li, Yazhou; Greig, Nigel H. (2019). Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.. ACS pharmacology & translational science, 2(2), 66-91. https://doi.org/10.1021/acsptsci.9b00003
MLA
Glotfelty, Elliot J, et al. "Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.." ACS pharmacology & translational science, 2019. https://doi.org/10.1021/acsptsci.9b00003
RethinkPeptides
RethinkPeptides Research Database. "Incretin Mimetics as Rational Candidates for the Treatment o..." RPEP-04197. Retrieved from https://rethinkpeptides.com/research/glotfelty-2019-incretin-mimetics-as-rational
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.